人绒毛膜促性腺激素与不良妊娠结局的关联:系统综述与Meta分析
该系统综述与Meta分析检索了Medline、Embase、PubMed和Cochrane(2021年11月),纳入185项研究,评估妊娠8至28周血清人绒毛膜促性腺激素(hCG)水平与胎儿及母体不良结局的关联。结果显示,hCG水平与胎盘介导的不良妊娠结局相关,早孕期高和低hCG水平均可为不良结局的早期预警信号。
要点
- 早孕期低hCG水平与子痫前期和宫内胎儿死亡相关,高hCG水平与子痫前期相关。
- 中孕期高hCG水平与宫内胎儿死亡和子痫前期相关。
- hCG水平与胎盘介导的不良妊娠结局相关,早孕期高和低hCG均可为早期预警信号。
核心结论
- hCG水平与胎盘介导的不良妊娠结局相关。
- 早孕期高和低hCG水平均可为不良结局的早期预警信号。
- 需进一步分析hCG亚型与妊娠结局,以确定这些发现在特定截断值下的诊断效用。
研究设计与样本
- 系统综述与Meta分析,检索Medline、Embase、PubMed和Cochrane(2021年11月),使用MeSH主题词和相关关键词。
- 纳入在妊娠8至28周进行血清hCG检测的孕妇的已发表全文研究,探讨胎儿结局(宫内胎儿死亡、小于胎龄儿、早产)或母体因素(妊娠期高血压:子痫前期、妊娠期高血压、胎盘早剥、HELLP综合征、妊娠期糖尿病)。
- 共纳入185项研究,包括宫内胎儿死亡(45项)、小于胎龄儿(79项)、早产(62项)、妊娠期高血压(107项)、妊娠期糖尿病(29项)、胎盘早剥(17项)和HELLP综合征(2项)。
- 使用REDCap软件提取研究,采用纽卡斯尔-渥太华量表评估偏倚风险,最终Meta分析采用GRADE方法进行质量评估。
- 根据hCG的分类测量和连续尺度测量分别分析数据,分类hCG水平生成合并比值比,连续尺度hCG生成结局组间中位数差。
主要发现
- 早孕期低hCG水平与子痫前期和宫内胎儿死亡相关。
- 早孕期高hCG水平与子痫前期相关。
- 中孕期高hCG水平与宫内胎儿死亡和子痫前期相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需进一步分析hCG亚型与妊娠结局,以确定这些发现在特定截断值下的诊断效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to evaluate the association between human chorionic gonadotropin and adverse pregnancy outcomes. DATA SOURCES: Medline, Embase, PubMed, and Cochrane were searched in November 2021 using Medical Subject Headings (MeSH) and relevant key words. STUDY ELIGIBILITY CRITERIA: This analysis included published full-text studies of pregnant women with serum human chorionic gonadotropin testing between 8 and 28 weeks of gestation, investigating fetal outcomes (fetal death in utero, small for gestational age, preterm birth) or maternal factors (hypertension in pregnancy: preeclampsia, pregnancy-induced hypertension, placental abruption, HELLP syndrome, gestational diabetes mellitus). METHODS: Studies were extracted using REDCap software. The Newcastle-Ottawa scale was used to assess for risk of bias. Final meta-analyses underwent further quality assessment using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) method. RESULTS: A total of 185 studies were included in the final review, including the outcomes of fetal death in utero (45), small for gestational age (79), preterm delivery (62), hypertension in pregnancy (107), gestational diabetes mellitus (29), placental abruption (17), and HELLP syndrome (2). Data were analyzed separately on the basis of categorical measurement of human chorionic gonadotropin and human chorionic gonadotropin measured on a continuous scale. Eligible studies underwent meta-analysis to generate a pooled odds ratio (categorical human chorionic gonadotropin level) or difference in medians (human chorionic gonadotropin continuous scale) between outcome groups. First-trimester low human chorionic gonadotropin levels were associated with preeclampsia and fetal death in utero, whereas high human chorionic gonadotropin levels were associated with preeclampsia. Second-trimester high human chorionic gonadotropin levels were associated with fetal death in utero and preeclampsia. CONCLUSION: Human chorionic gonadotropin levels are associated with placenta-mediated adverse pregnancy outcomes. Both high and low human chorionic gonadotropin levels in the first trimester of pregnancy can be early warning signs of adverse outcomes. Further analysis of human chorionic gonadotropin subtypes and pregnancy outcomes is required to determine the diagnostic utility of these findings in reference to specific cutoff values.
引用
- Peris M, Crompton K, Shepherd DA, et al. The association between human chorionic gonadotropin and adverse pregnancy outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023. PMID: 37572838. doi:10.1016/j.ajog.2023.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。